EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 12 March 2020

EU Industrial and Pharmaceutical Strategy: An Opportunity to Drive Europe’s Health and Growth

Nathalie Moll's blog post

As an industry, we welcome the publication of the Commission’s Industrial Strategy and look forward to the release of the roadmap for the upcoming Pharmaceutical Strategy. Both bring the future of Europe’s life sciences sector into sharp focus and both represent a unique opportunity to work together to reestablish Europe’s global leadership in medical innovation while ensuring access to new treatments and technologies today.

EFPIA has outlined steps that we believe that Europe can and should take and we look forward to engaging with all stakeholders in the coming months to realise our region’s potential for the benefit of today and tomorrow’s patients. The time is now. Read more

EU Industrial and Pharmaceutical Strategy

EFPIA response to the publication of the EU Industrial Strategy
10 March 2020

EFPIA notes the publication of the Industrial Strategy by the European Commission including a reference to the roadmap... Read more

The EU’s Industrial Strategy: Will Europe smile or will she not smile; that is the question...
11 March 2020 - Koen Berden

What the EU’s industrial policy can do is enhance the strengths already present in the EU economy and create a stronger... Read more

Events

DIA Europe 2020
29 June 2020 (Virtual Conference)

As a direct result of the outbreak of the coronavirus disease (COVID-19), DIA has decided to postpone DIA Europe 2020... Read more

c4c Multi-Stakeholder Meeting on Child Psychiatry
10 September 2020 (Brussels, Belgium)

The first c4c Multi-Stakeholder Meeting on Child Psychiatry seeks to facilitate dialogue and provide an opportunity... Read more

European pharmaceutical industry response to COVID-19

EFPIA update on research-based pharmaceutical industry response to COVID-19
11 March 2020 (News & Events)

The advent of a global health emergency such as coronavirus underlines the need for a collaborative, dynamic, responsive... Read more

What we are reading

European Industries welcome an important industry focus from the European Commission
On 11 March 2020 (Industry4Europe)

Industry4Europe, a coalition of 154 sector Associations representing the diversity of the EU’s industrial base, is pleased... Read more

A new European Industrial Strategy; the importance of securing a well-balanced vaccine ecosystem...
On 10 March 2020 (Vaccines Europe)

By Sue Middleton, President of Vaccines Europe Read more

COVID-19 is a sign of the times
On 10 March 2020 (IMI)

IMI Director Pierre Meulien says that repurposing existing drugs could get us out of the current predicament, but it’s... Read more

Vaccine Development: The Ebola Example
On 04 March 2020 (NY Times)

Dr. Julie Gerberding of Merck discusses the company’s effort in 2014 to respond to the West Africa outbreak. Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu